Characterization of receptor-interacting protein 140 in retinoid receptor activities

被引:60
作者
Lee, CH [1 ]
Wei, LN [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA
关键词
D O I
10.1074/jbc.274.44.31320
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Receptor-interacting protein 140 (RIP140) contains multiple receptor interaction domains and interacts with retinoic acid receptors in a ligand-dependent manner. Nine LXXLL receptor-interacting motifs are organized into two clusters within this molecule, each differentially interacting with retinoic acid receptor (RAR) and retinoid X receptor (RXR). RAR interacts with the 5' cluster, whereas RXR interacts with both clusters. Additionally, a third ligand-dependent receptor-interacting domain is assigned to the very C terminus of this molecule, which contains no LXXLL motif. In mammalian cells, receptor heterodimerization is required for efficient interaction of RAR/RXR with RIP140. Furthermore, the heterodimeric, holoreceptors cooperatively interact with RIP140, which requires the activation function 2 domains of both receptors, By using different retinoic acid reporter systems, it is demonstrates that RIP140 strongly suppresses retinoic acid induction of reporter activities, but coactivator SRC-1 enhances it. Furthermore, an intrinsic repressive activity of RIP140 is demonstrated in a GAL4 fusion system. Unlike receptor corepressor, which interacts with antagonist-bound RAR/RXRs, RIP140 does not interact with antagonist-occupied RAR/RXR dimers, These data suggest that RIP140 represents a third coregulator category that is able to suppress the activation of certain agonist-bound hormone receptors.
引用
收藏
页码:31320 / 31326
页数:7
相关论文
共 41 条
[1]   AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells [J].
Agarwal, C ;
Chandraratna, RAS ;
Johnson, AT ;
Rorke, EA ;
Eckert, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12209-12212
[2]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[3]  
Botling J, 1997, J BIOL CHEM, V272, P9443
[4]   NUCLEAR FACTOR RIP140 MODULATES TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR [J].
CAVAILLES, V ;
DAUVOIS, S ;
LHORSET, F ;
LOPEZ, G ;
HOARE, S ;
KUSHNER, PJ ;
PARKER, MG .
EMBO JOURNAL, 1995, 14 (15) :3741-3751
[5]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580
[6]   A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS [J].
CHEN, JD ;
EVANS, RM .
NATURE, 1995, 377 (6548) :454-457
[7]   Mechanisms of the mouse orphan nuclear receptor TR2-11-mediated gene suppression [J].
Chinpaisal, C ;
Lee, CH ;
Wei, LN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18077-18085
[8]   Estrogen receptors alpha and beta form heterodimers on DNA [J].
Cowley, SM ;
Hoare, S ;
Mosselman, S ;
Parker, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19858-19862
[9]   Structure and specificity of nuclear receptor-coactivator interactions [J].
Darimont, BD ;
Wagner, RL ;
Apriletti, JW ;
Stallcup, MR ;
Kushner, PJ ;
Baxter, JD ;
Fletterick, RJ ;
Yamamoto, KR .
GENES & DEVELOPMENT, 1998, 12 (21) :3343-3356
[10]   Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors [J].
Feng, WJ ;
Ribeiro, RCJ ;
Wagner, RL ;
Nguyen, H ;
Apriletti, JW ;
Fletterick, RJ ;
Baxter, JD ;
Kushner, PJ ;
West, BL .
SCIENCE, 1998, 280 (5370) :1747-1749